165 related articles for article (PubMed ID: 8456644)
1. Synovial fluid analyses detect and differentiate proteoglycan metabolism in canine experimental models of osteoarthritis and disuse atrophy.
Ratcliffe A; Beauvais PJ; Saed-Nejad F; Shurety W; Caterson B
Agents Actions Suppl; 1993; 39():63-7. PubMed ID: 8456644
[TBL] [Abstract][Full Text] [Related]
2. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse.
Ratcliffe A; Beauvais PJ; Saed-Nejad F
J Orthop Res; 1994 Jul; 12(4):464-73. PubMed ID: 7520485
[TBL] [Abstract][Full Text] [Related]
3. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy.
Ratcliffe A; Shurety W; Caterson B
Arthritis Rheum; 1993 Apr; 36(4):543-51. PubMed ID: 7681285
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.
Matyas JR; Atley L; Ionescu M; Eyre DR; Poole AR
Arthritis Rheum; 2004 Feb; 50(2):543-52. PubMed ID: 14872497
[TBL] [Abstract][Full Text] [Related]
5. Increased release of matrix components from articular cartilage in experimental canine osteoarthritis.
Ratcliffe A; Billingham ME; Saed-Nejad F; Muir H; Hardingham TE
J Orthop Res; 1992 May; 10(3):350-8. PubMed ID: 1569498
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis.
Ratcliffe A; Israel HA; Saed-Nejad F; Diamond B
J Oral Maxillofac Surg; 1998 Feb; 56(2):204-8. PubMed ID: 9461146
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis.
Lindhorst E; Vail TP; Guilak F; Wang H; Setton LA; Vilim V; Kraus VB
J Orthop Res; 2000 Mar; 18(2):269-80. PubMed ID: 10815829
[TBL] [Abstract][Full Text] [Related]
8. Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy.
Carroll G; McCappin S; Bell M; Schwarzer A; Breidahl P
Rheumatol Int; 1991; 11(2):63-8. PubMed ID: 1658913
[TBL] [Abstract][Full Text] [Related]
9. Changes in cartilage proteoglycan aggrecan after intra-articular injection of interleukin-1 in rabbits: studies of synovial fluid and articular cartilage.
Lundberg C; Asberg I; Ionescu M; Reiner A; Smedegård G; Poole AR
Ann Rheum Dis; 1996 Aug; 55(8):525-34. PubMed ID: 8774180
[TBL] [Abstract][Full Text] [Related]
10. Cartilage proteoglycan changes in experimental canine osteoarthritis.
Adams ME; Grant MD; Ho A
J Rheumatol; 1987 May; 14 Spec No():107-9. PubMed ID: 3625663
[TBL] [Abstract][Full Text] [Related]
11. Cartilage structure and metabolism and basic changes in degenerative joint disease.
Muir H
Aust N Z J Med; 1978; 8 Suppl 1():1-5. PubMed ID: 365155
[No Abstract] [Full Text] [Related]
12. Changes in cartilage metabolism in arthritis are reflected by altered serum and synovial fluid levels of the cartilage proteoglycan aggrecan. Implications for pathogenesis.
Poole AR; Ionescu M; Swan A; Dieppe PA
J Clin Invest; 1994 Jul; 94(1):25-33. PubMed ID: 7518830
[TBL] [Abstract][Full Text] [Related]
13. Changes in the chondroitin sulfate-rich region of articular cartilage proteoglycans in experimental osteoarthritis.
Cox MJ; McDevitt CA; Arnoczky SP; Warren RF
Biochim Biophys Acta; 1985 Jun; 840(2):228-34. PubMed ID: 3922432
[TBL] [Abstract][Full Text] [Related]
14. Changes in chondroitin sulphate structure induced by joint disease.
Hardingham T
Acta Orthop Scand Suppl; 1995 Oct; 266():107-10. PubMed ID: 8553837
[No Abstract] [Full Text] [Related]
15. Circulating keratan sulfate: a marker of cartilage proteoglycan catabolism in osteoarthritis.
Thonar EJ; Manicourt DM; Williams J; Lenz ME; Sweet MB; Schnitzer TJ; Otten L; Glant T; Kuettner KE
J Rheumatol Suppl; 1991 Feb; 27():24-6. PubMed ID: 2027120
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid markers of osteoarthritis in dogs.
Fox DB; Cook JL
J Am Vet Med Assoc; 2001 Sep; 219(6):756-61. PubMed ID: 11561649
[TBL] [Abstract][Full Text] [Related]
17. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury.
Hazell PK; Dent C; Fairclough JA; Bayliss MT; Hardingham TE
Arthritis Rheum; 1995 Jul; 38(7):953-9. PubMed ID: 7541993
[TBL] [Abstract][Full Text] [Related]
18. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog.
Chu Q; Lopez M; Hayashi K; Ionescu M; Billinghurst RC; Johnson KA; Poole AR; Markel MD
Osteoarthritis Cartilage; 2002 Aug; 10(8):662-9. PubMed ID: 12479389
[TBL] [Abstract][Full Text] [Related]
19. Elevated synovial fluid levels of interleukin-6 and tumor necrosis factor associated with early experimental canine osteoarthritis.
Venn G; Nietfeld JJ; Duits AJ; Brennan FM; Arner E; Covington M; Billingham ME; Hardingham TE
Arthritis Rheum; 1993 Jun; 36(6):819-26. PubMed ID: 8507225
[TBL] [Abstract][Full Text] [Related]
20. The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid.
Sharif M; Osborne DJ; Meadows K; Woodhouse SM; Colvin EM; Shepstone L; Dieppe PA
Br J Rheumatol; 1996 Oct; 35(10):951-7. PubMed ID: 8883432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
